• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name: nelatimotide and adegramotide (DSP-7888 dosing emulsion)
Date Designated: 09/18/2017
Orphan Designation: Treatment of brain cancer
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Sumitomo Pharma Oncology, Inc.
84 Waterford Drive
Marlborough, Massachusetts 01752
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.